Eyenovia to Host Investor Call to Discuss Recent Licensing Agreements Resulting in Total Potential License Payments and Development Cost Reimbursement and Savings of Approximately $100 Million Medical Device Investing
Sirona Biochem Signs Agreement with Global Pharmaceutical Company for Clinical Trial of its Novel Skincare Compound TFC-1067 Biotech Investing
Phase 2b/3 Trial Shows Efficacy of Filgotinib for the Induction and Maintenance of Remission in Moderately and Severely Active Ulcerative Colitis Biotech Investing
Abbott Receives FDA Emergency Use Authorization for its COVID-19 IgM Antibody Blood Test Medical Device Investing
Thermo Fisher Scientific Further Expands COVID-19 Test Portfolio with Two New Antibody Tests Medical Device Investing
Bausch Health Licenses Eyenovia's Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12 Medical Device Investing
Bristol Myers Squibb Presents Positive Late-Breaking Data from Phase 3 True North Trial Evaluating Zeposia in Adult Patients with Moderate to Severe Ulcerative Colitis Biotech Investing
Nutritional High Announces Approval of the Proposed Amendments to the 10% Senior Unsecured Convertible Debentures and Extension of the Term of the 12% Senior Secured Convertible Debentures Cannabis Investing News
Medtronic Donates Nearly $1 Million in Personal Protective Equipment to International Medical Corps for COVID-19 Response Efforts Medical Device Investing
Allergan Aesthetics To Present Data From 4 Abstracts At The 2020 American Society For Dermatologic Surgery Virtual Meeting Biotech Investing
